Search clinical trials for: Pegzilarginase

Total 4 results

Aeglea Biotherapeutics

Terminated

A Study of Safety of Weekly Subcutaneous Pegzilarginase in Subjects With Arginase 1 Deficiency

Arginase I Deficiency | Hyperargininemia

Canada
Aeglea Biotherapeutics

Completed

A Study of AEB1102 (Pegzilarginase) in Patients With Arginase I Deficiency (AEB1102)

Arginase I Deficiency | Hyperargininemia

United States, Canada, United Kingdom, Portugal
Aeglea Biotherapeutics

Completed

Efficacy and Safety of Pegzilarginase in Patients With Arginase 1 Deficiency

Arginase I Deficiency | Hyperargininemia

United States, Italy, Canada, France, United Kingdom, Austria, Germany
Aeglea Biotherapeutics
Merck Sharp & Dohme LLC

Completed

Pegzilarginase and Pembrolizumab for Extensive Disease Small Cell Lung Cancer

Small-cell Lung Cancer

United States, Puerto Rico

3

Subscribe